EN
全国服务热线:
0571-88211921


醋酸布美兰肽,Bremelanotide (PT-141) ,32780-32-8
产品简介


Product Name:Bremelanotide

Synonyms:PT-141, PT141


CAS No.:189691-06-3 ,1607799-13-2

Catalog No.:GT-A005


Key Specification:

Appearance:  White powder
Purity (HPLC) ≥98.0%

Single impurity≤1.0%
Acetate Content(HPLC)≤10.0%
Water Content (Karl Fischer) ≤8.0%

Peptide content≥80.0%


Package:

Vacuum-packed with aluminum foil bag or transparent bag. 500mg,1g, 10g,50g 100g per package with icebag. Or according to your request. 


Description:

Bremelanotide was developed by Palatin Technologies, it was first described in the literature in 2003 when it was known by the investigational code PT-141.Bremelanotide was granted FDA approval on 21 June 2019.


Storage:Cool dry place( Store at -20°C, away from the light)


Background:

Bremelanotide was developed by Palatin Technologies and was approved for use in the United States by FDA in June 21, 2019.


Remarks

Products currently covered by valid Patents are offered for R&D use.

Any patent infringement and resulting liability is solely at buyer risk.






联系方式

联系人:沈经理

电话:
0571-88211921
0571-88211951

手机:
13355716090
13735575465

邮箱:
sales@gotopbio.com
sales1@gotopbio.com